Stockreport

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease [Yahoo! Finance]

Kyverna Therapeutics, Inc.  (KYTX) 
PDF Kyverna Therapeutics will seek clearance of what could be the first marketed cell therapy for an autoimmune condition after the treatment succeeded in a pivotal trial i [Read more]